Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: preigu, Osnabrück, Alemania
EUR 43,30
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. The WTO Medicines Decision in light of its Utilization | Resolution or Resignation? | Marumo Nkomo | Taschenbuch | 80 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838373607 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 119,86
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Jun 2010, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 49,00
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate. 80 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: moluna, Greven, Alemania
EUR 41,05
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Nkomo Marumois a South African national and currently works with a leading Intellectual Property law firm. He holds two Master s degrees these include an LLM in International Trade and Investment Law from the University of Pretoria.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Jun 2010, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 49,00
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2010
ISBN 10: 383837360X ISBN 13: 9783838373607
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 49,59
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate.